½ÃÀ庸°í¼­
»óǰÄÚµå
1608873

±ºÀ¯ÀüüÇÐ ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Metagenomics Market, By Product, By Technology, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±ºÀ¯ÀüüÇÐ ½ÃÀåÀÇ 2024³â ½ÃÀå ±Ô¸ð´Â 21¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2031³â¿¡´Â 37¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 8.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 21¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR: 8.10% 2031³â ±Ý¾× Àü¸Á 37¾ï 7,000¸¸ ´Þ·¯
±×¸² : ±ºÀ¯ÀüüÇÐ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Metagenomics Market-IMG1

±ºÀ¯ÀüüÇÐÀº ¹Ì»ý¹°À» ¹è¾çÇÏÁö ¾Ê°í ȯ°æ »ùÇÿ¡¼­ Á÷Á¢ äÃëÇÑ À¯Àü ¹°ÁúÀ» ¿¬±¸ÇÏ´Â °ÍÀÔ´Ï´Ù. À̸¦ ÅëÇØ ¿¬±¸ÀÚµéÀº ƯÁ¤ ȯ°æ¿¡ ¼­½ÄÇÏ´Â ¹Ì»ý¹° ±ºÁýÀÇ Áý´Ü À¯Àüü¸¦ Á¶»çÇϰí, À̵éÀÌ ¾î¶»°Ô »óÈ£ ÀÛ¿ëÇϰí ÁÖº¯ ȯ°æ°ú »óÈ£ÀÛ¿ëÇÏ´ÂÁö¸¦ ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. °³º° ¹Ì»ý¹° Á¾À» ºÐ¸®Çϰųª ½ÇÇè½Ç¿¡¼­ ¹è¾çÇÒ Çʿ䰡 ¾ø´Â ±ºÀ¯ÀüüÇд ¹è¾çµÇÁö ¾ÊÀº ´ë´Ù¼ö ¹Ì»ý¹°ÀÇ À¯Àüü¸¦ Ư¼ºÈ­ÇÏ¿© ´Ù¾çÇÑ »ýÅÂÇÐÀû Æ´»õÀÇ »ý¹°ÇÐÀû ±¸¼º¿¡ ´ëÇÑ ´õ ³ÐÀº ½Ã¾ß¸¦ È®º¸ÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ±ºÀ¯ÀüüÇÐ ½ÃÀåÀÇ ¼ºÀåÀº À¯Àüü ¿¬±¸°³¹ß ºñ¿ë Áõ°¡, °¨¿°º´ À¯Çà Áõ°¡, ÇコÄɾî, Á¦¾à, »ý¸í°øÇÐ, ³ó¾÷ µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ±ºÀ¯ÀüüÇÐÀÇ Àû¿ë È®´ë°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¹æ´ëÇÑ ¾çÀÇ ¿°±â¼­¿­ µ¥ÀÌÅÍ »ý¼ºÀ¸·Î ÀÎÇØ µ¥ÀÌÅÍ °ü¸® ¹× ºÐ¼®¿¡ ´ëÇÑ ±â¼úÀû °úÁ¦°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ½Äǰ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÇ Áõ°¡¿Í ±ºÀ¯ÀüüÇÐÀ» Ȱ¿ëÇÑ ÇöÀå Áø´ÜÀÇ °³¹ßÀº ½ÃÀå Âü¿©Àڵ鿡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù.

º» ¿¬±¸ÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAG%)À» Á¦°øÇÏ´Â ¼¼°è ±ºÀ¯ÀüüÇÐ ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼® º¸°í¼­ÀÔ´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ±ºÀ¯ÀüüÇÐ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

¿¬±¸¿¡ Âü¿©ÇÑ ÁÖ¿ä ±â¾÷À¸·Î´Â Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd., PacBio µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

±ºÀ¯ÀüüÇÐ ½ÃÀå ºÐ¼® º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ±ºÀ¯ÀüüÇÐ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú °¡Á¤

  • ºÐ¼® ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå ¿ªÇС¤±ÔÁ¦¡¤µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ±â¾÷ ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • ½ÃÀå µ¿Çâ

Á¦4Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå, Á¦Ç°º°, 2019-2031³â, (10¾ï ´Þ·¯)

  • ½Ã¾à¡¤¼Ò¸ðǰ
  • Àåºñ
  • ½ÃÄö½Ì¡¤µ¥ÀÌÅÍ ºÐ¼® ¼­ºñ½º

Á¦5Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå : ±â¼úº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼¦°Ç ½ÃÄö½Ì
  • 16S ½ÃÄö½Ì
  • ÀüÀå À¯Àüü ½ÃÄö½Ì
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå : ¿ëµµº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Drug Discovery
  • ÀÓ»ó Áø´Ü
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Á¦¾à ±â¾÷
  • ¿¬±¸½Ç
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ±ºÀ¯ÀüüÇÐ ½ÃÀå : Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Novogene Co., Ltd.
  • Promega Corporation
  • QIAGEN
  • Takara Bio, Inc.
  • Oxford Nanopore Technologies
  • F.Hoffmann-La Roche Ltd
  • PacBio

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map(COM)

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • ºÐ¼® ¹æ¹ý
  • Coherent Market Insights¿¡ ´ëÇØ
ksm 24.12.23

The metagenomics market is estimated to be valued at USD 2.18 Bn in 2024 and is expected to reach USD 3.77 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 2.18 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 8.10% 2031 Value Projection: 3.77 Bn
Figure. Metagenomics Market Share (%), By Region 2024
Metagenomics Market - IMG1

Metagenomics is the study of genetic material recovered directly from environmental samples without cultivating the microorganisms. It allows researchers to study the collective genomes of microbial communities inhabiting a particular environment and understand how they interact with each other and their surroundings. By avoiding the need for isolation and laboratory cultivation of individual microbial species, metagenomics provides a cost-effective way to characterize the genomes of uncultured microbial majority and obtain a broader perspective of the biological composition of various ecological niches.

Market Dynamics:

The global metagenomics market growth is driven by increasing R&D spending on genomics, rising prevalence of infectious diseases, and growing applications of metagenomics across various industries like healthcare, pharmaceutical, biotechnology, and agriculture. However, technical challenges related to data management and analysis due to the huge amount of sequence data generated restrain the market growth. Growing food safety concerns and development of point-of-care diagnostics utilizing metagenomics provide lucrative opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global metagenomics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global metagenomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd, and PacBio

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global metagenomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metagenomics market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2019 - 2031)
    • Reagents & Consumables
    • Instruments
    • Sequencing & Data Analytics Services
  • Technology Insights (Revenue, USD Bn, 2019 - 2031)
    • Shotgun Sequencing
    • 16S Sequencing
    • Whole Genome Sequencing
    • Others
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Drug Discovery
    • Clinical Diagnostics
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical Companies
    • Research Laboratories
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific, Inc.
    • Novogene Co., Ltd.
    • Promega Corporation
    • QIAGEN
    • Takara Bio, Inc.
    • Oxford Nanopore Technologies
    • F.Hoffmann-La Roche Ltd
    • PacBio

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Metagenomics Market, By Product
    • Metagenomics Market, By Technology
    • Metagenomics Market, By Application
    • Metagenomics Market, By End User
    • Metagenomics Market, By Region

3. Global Metagenomics Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Market Trends

4. Global Metagenomics Market, By Product, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sequencing & Data Analytics Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Metagenomics Market, By Technology, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Shotgun Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • 16S Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Whole Genome Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Metagenomics Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Metagenomics Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Metagenomics Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Region, 2019 - 2031, Value (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novogene Co., Ltd.
  • Promega Corporation
  • QIAGEN
  • Takara Bio, Inc.
  • Oxford Nanopore Technologies
  • F.Hoffmann-La Roche Ltd
  • PacBio

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦